Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8104548 | 0.86 | PLK1 (0.36) | CYP3A4 | |
| SCHEMBL8716297 | 0.86 | NPC1 (0.30) | — | |
| SCHEMBL15854557 | 0.86 | LMNA (0.36) | LMNAALDH1A1TSHRMAPK1BCL2L1 | |
| SCHEMBL5081657 | 0.85 | PLK1 (0.40) | TSHR | |
| SCHEMBL20024340 | 0.84 | LMNA (0.37) | LMNAALDH1A1TSHRMAPK1CYP3A4 | |
| SCHEMBL7894750 | 0.84 | LMNA (0.37) | LMNAALDH1A1TSHRMAPK1CYP3A4 | |
| SCHEMBL23716866 | 0.83 | ALDH1A1 (0.34) | LMNAALDH1A1TSHRMAPK1CYP3A4 | |
| SCHEMBL38879 | 0.82 | PLK1 (0.39) | — | |
| SCHEMBL77079 | 0.82 | LMNA (0.33) | LMNAALDH1A1TSHRMAPK1BCL2L1 | |
| SCHEMBL6063843 | 0.82 | LMNA (0.33) | LMNAALDH1A1TSHRMAPK1BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010056452-A2 | DIMERIC CYANOACRYLATE COMPOUNDS AS RED-SHIFTED UV ABSORBERS | CYTEC TECHNOLOGY CORP. (US) | 2010-05-20 | — | — | WO | disclosed |
| US-20060173107-A1 | Graftable hindered amine light stabilizers | CIBA SPECIALTY CHEMICALS CORP. | 2006-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173107-A1 | Graftable hindered amine light stabilizers | IDO1, MAOA, TPH1 | LMNA 3349/4885ALDH1A1 50/4885TSHR 3853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.